REFERENCES
- Lemp M A. Report of the National Eye Institute/Industry Workshop on Clinical Trials in Dry Eyes. CLAO J 1995; 21: 221–232, [INFOTRIEVE], [CSA]
- Patel S J, Lundy D C. Ocular manifestations of autoimmune disease. Am Fam Physician 2002; 66: 991–998, [INFOTRIEVE], [CSA]
- Fujita M, Igarashi T, Sakane M, Yoshino S, Takahashi H. Correlation between dry eye and rheumatoid arthritis activity. Am J Ophthalmol 2005; 140(5)808–813, [INFOTRIEVE], [CROSSREF], [CSA]
- Arnett F C, Edworthy S M, Bloch D A, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315–324, [INFOTRIEVE], [CSA]
- Williams D L. Analysis of tear uptake by the Schirmer tear test strip in the canine eye. Vet Ophthalmol 2005; 8(5)325–330, [INFOTRIEVE], [CROSSREF], [CSA]
- Zhao J, Manthorpe R, Wollmer P. Surface activity of tear fluid in patients with primary Sjögren's syndrome. Clin Physiol Funct Imaging 2002; 22(1)24–27, [INFOTRIEVE], [CROSSREF], [CSA]
- McMonnies C, Ho A, Wakefield D. Optimum dry eye classification using questionnaire responses. Adv Exp Med Biol 1998; 438: 835–838, [INFOTRIEVE], [CSA]
- Zhang M, Chen J Q, Liu Z G, et al. Clinical characteristics of patients with dry eye syndrome. Zhonghua Yan Ke Za Zhi 2003; 39(1)5–9, [INFOTRIEVE], [CSA]
- Hikichi T, Yoshida A, Fukui Y, et al. Prevalence of dry eye in Japanese centers. Graefes Arch Clin Exp Ophthalmol 1995; 233: 555–558, [INFOTRIEVE], [CROSSREF], [CSA]
- Schaumber D A, Sullivan D A, Buring J E, Dana M R. Prevalence of dry eye syndrome among US women. Am J Ophthalmol 2003; 136: 318–326, [CROSSREF], [CSA]
- Moss S E, Klein R, Klein B EK. Incidence of dry eye in an older population. Arch Ophthalmol 2004; 122: 369–373, [INFOTRIEVE], [CROSSREF], [CSA]
- Jabs D. Ocular manifestations of rheumatic diseases. JB Lippincott, Philadelphia 1992; 1–5
- Lansbury J. Quantitation of the activity of rheumatoid arthritis. I. A method for recording its systemic manifestations. Am J Med Sci 1956; 231: 616–621, [INFOTRIEVE], [CSA]
- Mody G M, Hill J C, Meyers O L. Keratoconjunctivitis sicca in rheumatoid arthritis. Clin Rheumatol 1988; 7: 237–241, [INFOTRIEVE], [CROSSREF], [CSA]
- Ausayakhun S, Louthrenoo W, Aupapong S. Ocular diseases in patients with rheumatic diseases. J Med Assoc Thai 2002; 85: 855–862, [INFOTRIEVE], [CSA]
- Lopez Garcia J S, Garcia Loranzo I, Smaranda A, Martinez–Garchitorena J. But and Schirmer test comparative study in relation to dry eye etiology and severity. Arch Soc Esp Oftalmol 2005; 80(5)289–295, [INFOTRIEVE], [CSA]
- Jones D T, Monroy D, Ji Z, Pflugfelder S C. Alterations of ocular surface gene expression in Sjoegren's syndrome. Adv Exp Med Biol 1998; 438: 533–536, [INFOTRIEVE], [CSA]
- Tishler M, Yaron I, Geyer O, et al. Elevated tear interleukin–6 levels in patients with Sjogren syndrome. Ophthalmology 1998; 105: 2327–2329, [INFOTRIEVE], [CROSSREF], [CSA]
- Solomon A, Dursun D, Lui Z, et al. Pro– and anti–inflammatory forms of interleukin–1 in the tear fluid and conjunctiva of patients with dry–eye disease. Invest Ophthalmol Vis Sci 2001; 42: 2283–2292, [INFOTRIEVE], [CSA]
- Prada J, Noelle B, Baatz H, Hartmann C, Pleyer U. Tumor necrosis factor alpha and interleukin 6 gene expression in keratocytes from patients with rheumatoid corneal ulcerations. Br J Ophthalmol 2003; 87: 548–550, [INFOTRIEVE], [CROSSREF], [CSA]
- Begley C G, Caffery B, Chalmers R L, Mitchell G L, Dry Eye Investigation (DREI) Study Group. Use of the dry eye questionnaire to measure symptoms of ocular irritation in patients with aqueous tear deficient dry eye. Cornea 2002; 21(7)664–670, [INFOTRIEVE], [CROSSREF], [CSA]
- Nichols K K, Nichols J J, Mitchell G L. The lack of association between signs and symptoms in patients with dry eye disease. Cornea 2004; 23: 762–770, [INFOTRIEVE], [CROSSREF], [CSA]
- Shimazaki J, Goto E, Ono M, Shimmura S, Tsubota K. Meibomian gland dysfunction in patients of Sjogren syndrome. Ophthalmology 1998; 105(8)1485–1488, [INFOTRIEVE], [CROSSREF], [CSA]
- Krenzer K L, Dana M R, Ullman M D, et al. Effect of androgen deficiency on human meibomian gland function and the ocular surface. J Clin Endocrinol Metab 2000; 85(12)4874–4882, [INFOTRIEVE], [CROSSREF], [CSA]
- Mathers W D. Ocular evaporation in meibomian gland dysfunction and dry eye. Ophthalmology 1993; 100(3)347–351, [INFOTRIEVE], [CSA]
- Kujawa A, Rozycki R. Immunological phenomena in the pathology of the tear film. Is cyclosporine the turn point in Sjogren's syndrome treatment? Preliminary report. Klin Oczna 2004; 106(3 Suppl)489–491, [INFOTRIEVE], [CSA]
- Baudouin C. The pathology of dry eye. Surv Ophthalmol 2001; 45(Suppl 2)S211–220, [INFOTRIEVE], [CROSSREF], [CSA]
- Sendecka M, Baryluk A, Polz-Dacewicz M. Prevalence and risk factors of dry eye syndrome. Przegl Epidemiol 2004; 58(1)227–233, [INFOTRIEVE], [CSA]
- Horwath-Winter J, Berghold A, Schmut O, et al. Evaluation of the clinical course of dry eye syndrome. Arch Ophthalmol 2003; 121(10)1364–1368, [INFOTRIEVE], [CROSSREF], [CSA]
- Mertzanis P, Albertz L, Rajagopalan K, et al. The relative burden of dry eye in patients' lives: comparisons to a U.S. normative sample. Invest Ophthalmol Vis Sci 2005; 46(1)46–50, [INFOTRIEVE], [CROSSREF], [CSA]